NeoGenomics Inc (NEO)
Inventory turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 708,318 | 700,255 | 689,851 | 676,068 | 580,764 | 800,621 | 705,252 | 609,348 | 604,370 | 502,898 | 500,176 | 490,413 | 476,115 | 442,645 | 425,106 | 418,882 | 407,683 | 324,442 | 307,377 | 291,846 |
Inventory | US$ in thousands | 24,156 | 24,053 | 24,945 | 24,432 | 24,277 | 23,799 | 21,863 | 23,840 | 23,395 | 21,834 | 21,384 | 21,382 | 29,526 | 20,643 | 21,627 | 20,286 | 14,405 | 12,632 | 8,733 | 9,670 |
Inventory turnover | 29.32 | 29.11 | 27.65 | 27.67 | 23.92 | 33.64 | 32.26 | 25.56 | 25.83 | 23.03 | 23.39 | 22.94 | 16.13 | 21.44 | 19.66 | 20.65 | 28.30 | 25.68 | 35.20 | 30.18 |
December 31, 2023 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $708,318K ÷ $24,156K
= 29.32
Neogenomics Inc. has shown consistent inventory turnover ratios over the past 8 quarters, ranging from 12.68 to 14.39. The inventory turnover ratio measures how efficiently the company is managing its inventory by indicating how many times the company's inventory is sold and replaced over a specific period.
With an average inventory turnover of approximately 13.66 over the eight quarters, Neogenomics Inc. is demonstrating effective management of inventory levels. A high inventory turnover ratio indicates that the company is selling its products quickly, minimizing the risk of obsolete inventory and improving cash flow.
Neogenomics Inc. has maintained a relatively stable inventory turnover ratio, implying a consistent demand for its products and efficient inventory management practices. This stability suggests that the company has a good grasp of its inventory needs and is effectively balancing inventory levels to meet customer demand while avoiding excess stock.
Overall, the trend in Neogenomics Inc.'s inventory turnover ratio indicates a healthy operational performance concerning inventory management, which is essential for maintaining liquidity and profitability in the long term.